Amoxicillin vs. placebo to reduce symptoms in children with group A streptococcal pharyngitis: a randomized, multicenter, double-blind, non-inferiority trial
The trial is registered at the US National Institutes of Health (ClinicalTrials.gov) # NCT03264911 on 15.08.2017.
Authors
- Klara Maria Posfay-Barbe (ORCID: https://orcid.org/0000-0001-9464-5704)
- Juan Llor
- Natasha Loevy
- Laure F. Pittet (ORCID: https://orcid.org/0000-0002-2395-4574)
- Ulrich Heininger (ORCID: https://orcid.org/0000-0001-8901-6778)
- Renato Gualtieri (ORCID: https://orcid.org/0000-0001-8164-7284)
- Sandra Asner (ORCID: https://orcid.org/0000-0001-7911-0752)
- Marie Rohr (ORCID: https://orcid.org/0000-0002-3343-7028)
- Charlotte M. Verolet (ORCID: https://orcid.org/0000-0003-3419-1434)
- Chiara Mardegan (ORCID: https://orcid.org/0009-0000-1999-6045)
- Sébastien Papis (ORCID: https://orcid.org/0000-0001-8100-5230)
- Laurence Lacroix
Institutions
- University of Geneva (CH)
- University Hospital of Geneva (CH)
- University Children’s Hospital Basel (CH)
- Hôpital du Valais (CH)
- Geneva College (US)
- University of Lausanne (CH)
Publication Details
- Journal
- European Journal of Pediatrics
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1007/s00431-024-05705-1
- Citations
- 4
- Primary Topic
- Streptococcal Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.17
Funders
- Hôpitaux Universitaires de Genève
- Université de Genève
- Centre Hospitalier Universitaire Vaudois
- Société Académique de Genève
- Gertrude von Meissner-Stiftung